Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 10Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 7Pancreatic Neoplasms 5Neoplastic Cells, Circulating 4Neoplasm Metastasis 4Biliary Tract Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Prostatic Neoplasms 3Oropharyngeal Neoplasms 3Neoplasm, Residual 3Disease 3Nevi and Melanomas 2Neuroendocrine Tumors 2Neoplasms 2Nasopharyngeal Carcinoma 2NSCLC 2Melanoma 2Head and Neck Neoplasms 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Smoking 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Liquid Biopsy × Clear all
NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Recruiting
3,500 enrolled

Neoplasms, Recurrence

NCT05254132 2022-02-24

SALMON

OncoRadiomics

Unknown
1,000 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡